Spore.Bio's AI microfluidic device cuts bacterial-contamination testing from weeks to real time

What Happened

Paris DeepTech startup Spore.Bio (built on Pasteur Institute research, backed by a €22M Series A) patented a microfluidic device paired with machine-learning analytics that detects bacterial contamination on-site in real time, versus the 5-20 days traditional lab testing requires — aimed squarely at the rising cost of food-safety recalls.

Why It Matters

Cutting contamination detection from 5-20 days to real-time changes the economics of a recall entirely — most of the cost of a food-safety recall comes from how much product ships before the problem is caught.

From weeks to real-time — that's not an incremental improvement, it's a different economics.

FET's Takeaway

Pasteur Institute research as the technical foundation is a meaningful credibility signal for a microfluidic diagnostic claiming lab-grade accuracy on-site — that pedigree is what will get quality managers to trust it over incumbent lab-send-out testing.